Mohamad Mukhtar - Millennium Pharmacon President Director
SDPC Stock | IDR 144.00 1.00 0.69% |
President
Mr. Mohamad Muhazni bin Mukhtar serves as President Director of PT Millennium Pharmacon International Tbk since October 18, 2012. He obtained American Associate degree from Indiana University in 1988, Bachelor of Business Administration in Management Science from University of Iowa in 1990, MBA from Ohio UniversityUniversiti Teknologi MARA in 1993, and MS in Business Leadership from Newcastle Business School, Northumbria University in 2010. He has worked with London Pacific Insurance Bhd in 1991, Plus Expressway Bhd from 1993 until 1996, Touch and Go Sdn Bhd, Faber Group Bhd and Faber Facilities Sdn Bhd. He is a member of Company Management Risk Committee. since 2012.
Age | 46 |
Tenure | 12 years |
Professional Marks | MBA |
Phone | 62 21 270 85961 |
Web | https://www.mpi-indonesia.co.id |
Millennium Pharmacon Management Efficiency
The company has return on total asset (ROA) of 0.0342 % which means that it generated a profit of $0.0342 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0938 %, meaning that it generated $0.0938 on every $100 dollars invested by stockholders. Millennium Pharmacon's management efficiency ratios could be used to measure how well Millennium Pharmacon manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | PRESIDENT Age | ||
Gidion Hasan | United Tractors Tbk | 46 | |
John Gledhill | Hanjaya Mandala Sampoerna | 65 | |
Jahja Setiaatmadja | Bank Central Asia | 67 | |
Joseph Godong | Bank Mandiri Persero | 56 | |
Agus Noorsanto | Bank Rakyat Indonesia | 54 | |
Kepas Manurung | Bank Mandiri Persero | N/A | |
Andrinof Chaniago | Bank Rakyat Indonesia | 56 | |
Wimboh Santoso | Bank Mandiri Persero | 58 | |
Toni Subari | Bank Mandiri Persero | 59 | |
Charles Bendotti | Hanjaya Mandala Sampoerna | 42 | |
Budi Sadikin | Bank Mandiri Persero | 50 | |
David Newbigging | United Tractors Tbk | 43 | |
Imam Putro | Bank Mandiri Persero | 53 | |
Alexandra Askandar | Bank Mandiri Persero | 51 | |
Rico Frans | Bank Mandiri Persero | 47 | |
Ventje Rahardjo | Bank Mandiri Persero | 62 | |
Hartadi Sarwono | Bank Mandiri Persero | 66 | |
Djony Tjondro | Astra International Tbk | 59 | |
Hexana Sasongko | Bank Rakyat Indonesia | 51 | |
Pradjoto | Bank Negara Indonesia | 62 | |
Mustaslimah | Bank Mandiri Persero | 52 |
Management Performance
Return On Equity | 0.0938 | |||
Return On Asset | 0.0342 |
Millennium Pharmacon Leadership Team
Elected by the shareholders, the Millennium Pharmacon's board of directors comprises two types of representatives: Millennium Pharmacon inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Millennium. The board's role is to monitor Millennium Pharmacon's management team and ensure that shareholders' interests are well served. Millennium Pharmacon's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Millennium Pharmacon's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mohamad Hassan, F Director | ||
Glenn Ariff, Unaffiliated Director | ||
Aris, Chairman Audit | ||
Dian Anggreni, Legal and Corporate Secretary | ||
Ernie Hilal, Corporate Secretary | ||
Yungkis Sucandra, Head Unit | ||
Ahmad Bakar, Pres Director | ||
Mohamad Mukhtar, President Director | ||
Morsela, Ma Marketing | ||
Puji Hartono, Head Unit | ||
Nyoman Rai, Independent Commissioner | ||
Dedi Martadiredja, Sr Sales | ||
Ivan Hanafi, Independent Director | ||
Olga Bolang, Co Sec | ||
Noraini Ali, Commissioner | ||
Izzat Othman, President Commissioner, Independent Commissioner | ||
Yuni Arrivani, Deputy Legal | ||
Mohamed Rahman, Commissioner |
Millennium Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Millennium Pharmacon a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0938 | |||
Return On Asset | 0.0342 | |||
Profit Margin | 0.01 % | |||
Operating Margin | 0.02 % | |||
Current Valuation | 828.27 B | |||
Shares Outstanding | 1.27 B | |||
Shares Owned By Insiders | 87.94 % | |||
Shares Owned By Institutions | 3.35 % | |||
Price To Earning | 9.31 X | |||
Price To Book | 1.16 X |
Currently Active Assets on Macroaxis
ABBV | AbbVie Inc | |
HBI | Hanesbrands | |
MIDU | Direxion Daily Mid | |
V | Visa Class A | |
ORCL | Oracle |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Millennium Pharmacon International. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Millennium Stock analysis
When running Millennium Pharmacon's price analysis, check to measure Millennium Pharmacon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Millennium Pharmacon is operating at the current time. Most of Millennium Pharmacon's value examination focuses on studying past and present price action to predict the probability of Millennium Pharmacon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Millennium Pharmacon's price. Additionally, you may evaluate how the addition of Millennium Pharmacon to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |